Beating heart myocardial revascularization on extracorporeal circulation in patients with endstage coronary artery disease

被引:17
|
作者
Prifti, E
Bonacchi, M
Frati, G
Giunti, G
Proietti, P
Leacche, M
Massetti, M
Babatasi, G
Sani, G
机构
[1] Policlin Careggi, Div Cardiochirurg, I-50134 Florence, Italy
[2] IRCCS, NEUROMED, I-86077 Isernia, Pozzilli, Italy
[3] Univ Siena, Ist Chirurg Torac Cardiovasc & Tecnol Biomed, I-53100 Siena, Italy
[4] Dept Cardiothorac Surg, Caen, France
[5] Osped Maggiore Carita Novara, Div Cardiochirurg, Novara, Italy
来源
CARDIOVASCULAR SURGERY | 2001年 / 9卷 / 06期
关键词
end-stage coronary artery disease; on-pump/beating-heart; coronary artery bypass grafting;
D O I
10.1016/S0967-2109(01)00092-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To evaluate in a cohort of ESCAD patients (pts) the effects of on-pump/beating-heart versus conventional CABG in terms of early and mid-term survival and morbidity and LV function improvement. Methods: Between January 1993 and December 2000, 78 (Group I) ESCAD pts underwent on-pump/beating-heart surgery. Mean age in Group I was 66.2+/-6 (58-79), NYHA and CCS class were 3.2+/-0.6 and 3.3+/-0.4 respectively, Myocardial viability index 0.69+/-0.1 (%), LVEF (%) 24.8+/-4, LVEDP (mmHg) 28.1+/-5.8 and LVEDD(mm) 69.5+/-6. Group II consisted in 78 ESCAD patients undergoing conventional CABG selected in a randomized fashion from an age, sex, and LVEF corrected group of patients. Mean age in Group II was 65.7+/-5 (57-78), NYHA 3.1+/-0.7. CCS 3.4+/-0.8. LVEF(%) 25+/-5, LVEDP(mmHg) 27.9+/-4.4 and LVEDD(mm) 69.2+/-7.2. Results: Postoperatively, 5(7.7%) patients died in Group I versus 7(11.5%) patients in Group II (P >0.1). CPB time resulted to be in Group II patients (P = 0.001) and the mean distal anastomoses per patient was similar between groups (P = Ns). Perioperative AMI (P = 0.039). LCOS (P = 0.002), necessity for ultrafiltration (P = 0.018) and bleeding> 1000 ml (P = 0.029) were significantly higher in Group II. None of the Group I patients underwent surgical revision for bleeding versus 8(10.3%) patients in Group II (P = 0.011). At 6 months after surgery, the LV function improved significantly in Group I patients, demonstrated by an increased LVEF = 27.24(%)(P = 0.001), lower LVEDP = 26.4+/-3(mmHg)(P = 0.029) and LVEDD = 67+/-4 (mm) (P = 0.004) instead of a lower LVEDD = 66.8+/-6(mm) (P = 0.032) versus the preoperative data in Group [I. The actuarial survival at 1, 3 and 5 yr were 90, 82 and 71% in Group I and 89, 83 and 74% in Group II (P = Ns). Conclusion: In ESCAD patients who may poorly tolerate cardioplegic arrest, on-pump/beating-heart CABG may be an acceptable alternative associated with lower postoperative mortality and morbidity. Such a technique offers a better myocardial and renal protection associated with lower postoperative complications due to intraoperative hypoperfusion. (C) 2001 Published by Elsevier Science Ltd on behalf of The International Society for Cardiovascular Surgery.
引用
收藏
页码:608 / 614
页数:7
相关论文
共 50 条
  • [21] Coronary revascularization with or without extracorporeal circulation
    Molnar, A
    Scridon, T
    Barsan, M
    FRONTIERS IN CORONARY ARTERY DISEASE, 2003, : 737 - 743
  • [22] Complete myocardial revascularization on the beating heart
    Kwon, K
    Jenkins, D
    Firpo, R
    Tzeng, T
    Craig, J
    AMERICAN JOURNAL OF SURGERY, 1999, 178 (06): : 501 - 504
  • [23] MYOCARDIAL REVASCULARIZATION FOR TREATMENT OF CORONARY ARTERY DISEASE
    MONK, I
    DEAL, C
    DONNELLY, GL
    MEDICAL JOURNAL OF AUSTRALIA, 1969, 1 (20) : 1009 - &
  • [24] Triple coronary artery revascularization on the stabilized beating heart: Initial experience
    Cartier, R
    Hebert, Y
    Blain, R
    Tremblay, N
    Desjardins, J
    Leclerc, Y
    CANADIAN JOURNAL OF SURGERY, 1998, 41 (04) : 283 - 288
  • [25] Risk assessment in patients with coronary artery disease undergoing myocardial revascularization
    Ilyukhin, O. V.
    Dronova, E. P.
    Temrisultanova, T. H.
    Lopatin, Y. M.
    EUROPEAN HEART JOURNAL, 2011, 32 : 547 - 547
  • [26] Outcomes of myocardial revascularization in patients with obesity and multivessel coronary artery disease
    Madiyeva, Maira I.
    Aripov, Marat A.
    Goncharov, Alexey Y.
    Zholdasbekova, Rakhima Y.
    EGYPTIAN HEART JOURNAL, 2024, 76 (01):
  • [27] Myocardial Revascularization of the beating heart in high-risk patients
    D'Ancona, G
    Karamanoukian, H
    Kawaguchi, AT
    Ricci, M
    Salerno, TA
    Bergsland, J
    JOURNAL OF CARDIAC SURGERY, 2001, 16 (02) : 132 - 139
  • [28] Myocardial revascularization in patients with coronary heart disease and type 2 diabetes
    Bezdenezhnyh, Natalya A.
    Sumin, Aleksey N.
    DIABETES MELLITUS, 2016, 19 (06): : 471 - 478
  • [29] Coronary artery bypass grafting on the beating heart: surgical revascularization for the next decade?
    Murphy, GJ
    Ascione, R
    Angelini, GD
    EUROPEAN HEART JOURNAL, 2004, 25 (23) : 2077 - 2085
  • [30] Octopus coronary revascularization without extracorporeal circulation
    Oster, H
    ZEITSCHRIFT FUR KARDIOLOGIE, 1999, 88 : 10 - 14